Mouse Pluripotent Stem Cell Differentiation Under Physiological Oxygen Reduces Residual Teratomas
Overview
Affiliations
Introduction: Residual pluripotent stem cells (PSC) within differentiated populations are problematic because of their potential to form tumors. Simple methods to reduce their occurrence are needed.
Methods: Here, we demonstrate that control of the oxygen partial pressure (pO) to physiological levels typical of the developing embryo, enabled by culture on a highly oxygen permeable substrate, reduces the fraction of PSC within and the tumorigenic potential of differentiated populations.
Results: Differentiation and/or extended culture at low pO reduced measured pluripotency markers by up to four orders of magnitude for mouse PSCs (mPSCs). Combination with cell sorting increased the reduction to as much as six orders of magnitude. Upon implantation into immunocompromised mice, mPSCs differentiated at low pO either did not form tumors or formed tumors at a slower rate than at high pO
Conclusions: Low pO culture alone or in combination with other methods is a potentially straightforward method that could be applied to future cell therapy protocols to minimize the possibility of tumor formation.
Hogrebe N, Schmidt M, Augsornworawat P, Gale S, Shunkarova M, Millman J bioRxiv. 2024; .
PMID: 39484596 PMC: 11526947. DOI: 10.1101/2024.10.21.618465.
Engineered IRES-mediated promoter-free insulin-producing cells reverse hyperglycemia.
Li Y, Younis D, He C, Ni C, Liu R, Zhou Y Front Endocrinol (Lausanne). 2024; 15:1439351.
PMID: 39279997 PMC: 11392723. DOI: 10.3389/fendo.2024.1439351.
Grattoni A, Korbutt G, Tomei A, Garcia A, Pepper A, Stabler C Nat Rev Endocrinol. 2024; 21(1):14-30.
PMID: 39227741 DOI: 10.1038/s41574-024-01029-0.
Identification of unique cell type responses in pancreatic islets to stress.
Maestas M, Ishahak M, Augsornworawat P, Veronese-Paniagua D, Maxwell K, Velazco-Cruz L Nat Commun. 2024; 15(1):5567.
PMID: 38956087 PMC: 11220140. DOI: 10.1038/s41467-024-49724-w.
Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes.
Hogrebe N, Ishahak M, Millman J Cell Stem Cell. 2023; 30(5):530-548.
PMID: 37146579 PMC: 10167558. DOI: 10.1016/j.stem.2023.04.002.